Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–5 of 5 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06995677
- Conditions
- Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
- Locations
-
- Urology Centers of Alabama Homewood, Alabama, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Tri Valley Urology - Murrieta Murrieta, California, United States
- Eisenhower Medical Associates Rancho Mirage, California, United States
NCT06915753
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCSF Medical Center at Mount Zion San Francisco, California, United States
- Stanford Cancer Institute Stanford, California, United States
- The University of Kansas Medical Center Westwood, Kansas, United States
NCT02965378
- Conditions
- FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification, +5 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
NCT04917809
- Conditions
- Bladder Cancer, Carcinoma, FGFR3 Gene Mutation, +15 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
NCT05544552
- Conditions
- Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- UMass Memorial Medical Center Worchester, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
- Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States